SPIRIT II Study: a clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo, native coronary artery lesions. 

 


 available
 


 available
Session Number : 709005
Session Title: Hotline II

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.